Organoid Startup Raises $21M to Test Drugs and Vaccines in Human Lymph Nodes-in-a-Dish

A startup focused on organoid technology has raised $21 million to develop and use human lymph node organoids ("lymph nodes-in-a-dish") for the testing of drugs and vaccines.

Organoids are lab-grown, miniature versions of human organs, allowing researchers to simulate real human tissue for drug discovery and disease modeling.

Recent funding initiatives, such as a $21 million investment in advanced organoid research models, are part of a broader movement to improve preclinical testing and accelerate the development of new therapies using more accurate human tissue models1.

By creating lymph node organoids, the startup aims to provide a platform for more precise and predictive drug and vaccine testing, potentially reducing reliance on animal models and speeding up biomedical research.

These lymph node-in-a-dish models could revolutionize the way new treatments for infectious diseases, cancer, and immune disorders are developed and validated.

Sources:

1. https://practicalneurology.com/news/21-million-in-research-funding-announced-for-neurofibromatosis/2470479/